4-methoxyamphetamine has been researched along with Diabetic Angiopathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raspovic, KM; Suder, NC; Wukich, DK | 1 |
| Bondi, M; Cappelli, C; Cavani, R; Evandri, V; Ghidoni, I; Giovanardi, P; Magnavacchi, P; Mannucci, C; Messora, R; Romano, S; Scarlini, S; Tondi, S; Turrini, F; Zanasi, A | 1 |
| Hirayama, A; Kasama, S; Kato, M; Matsumoto, N; Nagao, K; Nakano, Y; Sato, Y; Suzuki, Y; Yoda, S | 1 |
| Adamopoulou, EN; Argyrakis, SK; Foussas, SG; Handanis, SM; Lyras, AG; Makrygiannis, SS; Papantonakos, A; Prekates, AA; Psarogianni, PK; Zairis, MN | 1 |
| Cavusoglu, E; Chopra, V; Clark, LT; Eng, C; Marmur, JD; Pinsky, DJ | 1 |
| Mancini, GB; Stewart, DJ | 1 |
2 trial(s) available for 4-methoxyamphetamine and Diabetic Angiopathies
| Article | Year |
|---|---|
Does coronary Atherosclerosis Deserve to be Diagnosed earlY in Diabetic patients? The DADDY-D trial. Screening diabetic patients for unknown coronary disease.
Topics: Asymptomatic Diseases; Coronary Artery Disease; Death; Diabetic Angiopathies; Early Diagnosis; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction | 2015 |
Why were the results of the Heart Outcomes Prevention Evaluation (HOPE) trial so astounding?
Topics: Angiotensin-Converting Enzyme Inhibitors; Death; Diabetes Complications; Diabetic Angiopathies; Female; Heart Diseases; Humans; Male; Middle Aged; Ramipril; Vitamin E | 2001 |
4 other study(ies) available for 4-methoxyamphetamine and Diabetic Angiopathies
| Article | Year |
|---|---|
Patients With Diabetic Foot Disease Fear Major Lower-Extremity Amputation More Than Death.
Topics: Aged; Amputation, Surgical; Cohort Studies; Confidence Intervals; Death; Diabetes Complications; Diabetic Angiopathies; Diabetic Foot; Diabetic Nephropathies; Fear; Female; Humans; Male; Middle Aged; Odds Ratio; Prospective Studies; Surveys and Questionnaires | 2018 |
Combined assessment of myocardial perfusion and function by ECG-gated myocardial perfusion single-photon emission computed tomography for the prediction of future cardiac events in patients with type 2 diabetes mellitus.
Topics: Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Death; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Forecasting; Heart Failure; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Proportional Hazards Models; Prospective Studies | 2011 |
Type 2 diabetes and intravenous thrombolysis outcome in the setting of ST elevation myocardial infarction.
Topics: Aged; Cohort Studies; Death; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; Female; Fibrinolytic Agents; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recovery of Function; Risk; Single-Blind Method; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator | 2004 |
Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography.
Topics: Acute Disease; Aged; Chemokine CCL5; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Death; Diabetic Angiopathies; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Referral and Consultation; Syndrome; Time Factors | 2007 |